c-RET

c-RET

c-RET related products

Structure Cat No. Product Name CAS No. Product Description
V0048 Regorafenib (BAY73-4506) 755037-03-7 Regorafenib (also known as BAY 73-4506; BAY-73-4506) is a potent andorally bioavailable multi-kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 values of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively.
V0071 Regorafenib HCl (BAY-73-4506) 835621-07-3 Regorafenib HCl, the hydrochloric acid salt of regorafenib (also known as BAY 73-4506), is a potent inhibitor of multi-kinase including VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 values of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively.
V0072 Regorafenib monohydrate (BAY73-4506) 1019206-88-2 Regorafenib monohydrate(also known as BAY 73-4506 monohydrate), the hydrated form ofRegorafenib, is an orally bioavailable multi-kinase inhibitor targeting kinases such as VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 values of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively.
V0050 TG-101209 936091-14-4 TG101209 is a novel, potent, orally bioactive and selective small molecule JAK2 inhibitor with IC50 of 6 nM.
Contact Us